Table 1.
Clinical outcomes extracted from selected papers.
| Outcomes | N | % | Included in Meta-Analysis |
|---|---|---|---|
| Mortality | 100 | 98% | Yes |
| Bleeding | 60 | 59% | Yes |
| Duration of support | 60 | 59% | Yes |
| Ischemic stroke | 50 | 49% | Yes |
| Renal failure | 44 | 43% | Yes |
| Limb ischemia | 40 | 39% | Yes |
| Bridge to LVAD | 30 | 29% | Yes |
| Weaning | 27 | 26% | Yes |
| Days in hospital/ICU | 25 | 25% | No |
| Bridge to transplant | 23 | 23% | Yes |
| Hemolysis | 22 | 22% | No |
| Sepsis | 20 | 20% | No |
| Myocardial recovery | 10 | 10% | Yes |
| Major device malfunction | 8 | 8% | No |
| Average Impella pump flow | 6 | 6% | No |
| Device exchange | 5 | 5% | No |
| Resource use | 5 | 5% | No |
| Aortic valve injury | 3 | 3% | No |
| Mitral valve injury | 3 | 3% | No |
| LV perforation | 0 | 0% | No |
| Aortic dissection | 0 | 0% | No |
| Early mobilization and physiotherapy | 0 | 0% | No |
| Average Impella performance level | 0 | 0% | No |
| Quality of life | 0 | 0% | No |